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1. production 
High density lipoproteins (HDL) are isolated from 
plasma in the density range between 1.063 and 1.2 10 
mg/ml and constitute a heterogeneous lipoprotein 
family [ 11. Subfractionation of HDL by ultracentrif- 
ugal procedure into HDLa (d = 1.063-l ,125) and 
HDLa (d = 1.125-l .210 mg/ml) has indicated that 
the two subclasses may have different physiological 
roles 121. Current interest in the HDL physiology has 
been stimulated by the observation that increased 
HDC, cholesterol levelsor high ~~~HDLs ratios 
may be better correlated with a negative coronary 
risk than the whole HDL cholesterol levels, as generally 
maintained [3-51. 
Studies on the regulation of the HDb and HDLJ 
levels in plasma have been numerous, Evidence has 
been indicated that HDLa may be the precursor of 
HDb,, consequently to the transfer to HDLa of apo- 
protein subfractions and surface cholesterol esters, 
deriving from the breakdown of triglyceride-rich lipo- 
proteins 161. The HDL~~HDL~ ratio may be reduced 
fo~owing diets rich in polyunsaturated fatty acids 
[7] or, conversely, increased by drug treatments, 
such as with nicotinic acid and clofibrate [S]. 
The liver appears to be a major catabolic site for 
HDL [ 11. Liver cells may also have high affinity up- 
take sites for the HDL apoproteins [9,10]. 
To identify differences in the catabolic pattern in 
liver of HDL and HDLa, an in vitro system of non- 
proliferating rat liver cells was used. This allows the 
maintenance of viabie monolayer hepatocytes, in the 
complete absence of non-parenchym~ cells, for < 48 
h [ 1 I]. The effect of pharmacologi~l concentrations 
of heparin in the system were also evaluated. 
2. Materials and methods 
Sprague-Dawley male rats (250-300 g) were used 
for lipoprotein collection and for the preparation of 
hepatocytes. Blood was held on ice in test tubes, con- 
taining EDTA (final cont. 0 .O I5 M) from animals 
fasted for 12-14 h. Lipoprotein cholesterol labelling in 
vivo was achieved by the injection of 1 mCi [ 1 ,2-3H]- 
cholesterol (spec. act, 58 Ci/mmol, The Radiochemical 
Center, Amersham) into the tail vein of rats 16 h 
before bleeding. The HDLa and HDLa subfractions 
were separated from the other lipoproteins by sequen- 
tial uitracentrifugation [ 121, followed by extensive 
dialysis against 500 vol. saline EDTA (pH 7.4). 
Free cholesterol of HDLz and HDLa was further 
labelled by incubating separated lipoproteins for 3-4 
h at 37’C in silanized vials containing 25 PC1 [4-14C]- 
cholesterol (spec. act. 58.4 Ci/mmol, The Radiochem- 
ical Center, Amersham) [ 131. The final specific activ- 
ity of free cholesterol (3H-14C) ranged from 5940- 
7510 dpm/,ug and 10 800-14 320 dpmlpg, respec- 
tively; that of esterified [3H]cholesterol between 
6000-6690 dpm/~g. Chemical analysis of the sepa- 
rated-hpoprotein classes was performed as in [ 141. 
Rat liver cell monolayer cultures were prepared 
generally as in [ 151, with the exception that the 
CMRL 1969 formulation was included into the per- 
fusion medium [161. Parenchymal cells were seeded 
at 3-7 X 104/cm2 density into 25 cm2 Corning flasks. 
The culture medium was composed of 80% (v/v) 
CMRL 1969 and 20% (v/v) decomplemented rabbit 
serum. Porcine insulin (Sigma) was added at 0.5 @g/ 
ml final cont. Cell incubation was performed in 
hu~di~ed air incubator at 37°C. The medium was 
changed 2h after seeding and 24 h thereafter, at 
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which time rabbit serum was substituted for an equal 
amount of lipoprotein deficient rabbit serum (LPDS) 
[ 171. The labelled lipoproteins were added at the 
same time and a further incubation performed as des- 
cribed in the figure legends. 
After incubation, the monolayers were washed 3 
times with cold phosphate buffer and the cells scraped 
off with a rubber policeman. Lipids from the recover- 
ed cellular pellet were extracted according to the 
Folch procedure [ 181. The free and esterified choles- 
terol bound radioactivity was determined by TLC 
separation of cellular lipids [ 191. The silica gel zones 
corresponding to the sterols were scraped off, added 
to 5 ml Lipoluma (Lumac) and counted in a Packard 
liquid scintillation counter. Efficiency of lipid extrac- 
tion and counting was determined by appropriate 
standards. Cellular protein contents of the lyophilized 
aqueous phase of the Folch extracts were measured 
following [20] using albumin as standard. 
Lipoprotein free cholesterol entering the cells was 
determined as follows: 
pg FC entered = 
(dpm [r4C]FC t dpm [‘*Cl EC) 
spec. act. [‘“Cl FC 
(1) 
Free cholesterol entering the cells and ultimately 
esterified was: 
pg FC esterified = dpm [14C] EC/spec. act. [‘“Cl FC 
(2) 
It is apparent from table 2 that the esterification rate 
of free cholesterol is very low. The flux of lipoprotein 
esters entering cells was therefore calculated from: 
kg EC entered) (spec. act. [3H]EC) = dpm [14C]FC 
- (dpm [14C],FC) (spec. act. [3H]FC)/ 
spec. act. [14C]FC 
+ dpm [3H]EC (3) 
The first addendum in (3) represents the mass of 
hydrolyzed cholesterol esters, whereas the second ad- 
dendum is the mass of cholesterol esters interiorized 
by the hepatocytes, but not hydrolyzed. 
In these formulae symbols are as follows: [‘HI FC 
and [ 3H] EC, tritium-labelled free and esterified cho- 
lesterol; [ 14C] FC and [ 14C] EC, carbon-labelled free 
and esteritied cholesterol. 
Loss of cholesterol from cells was preliminarily 
evaluated by incubation with [ 1 -14C]acetate and deter- 
mination of cholesterol-associated radioactivity in 
medium, in the presence of HDLZ and HDL3. The 
outflow was <I 8% of cell-associated cholesterol radio- 
activity. No corrections were therefore introduced for 
cell cholesterol loss. 
Heparin extracted from pig duodenum (170 U/mg) 
was from Calbiochem. 
3. Results and discussion 
In rats, in contrast to the human findings [2], only 
20% of HDL cholesterol is associated with HDL3 
(table 1). The monolayer model offers the opportunity 
of following the fate of HDLz and HDL3 associated 
cholesterol. The hepatic uptake of HDL? cholesterol 
esters, at similar lipoprotein concentrations, was 
5-times higher than that of HDL3 (table 2). Since ester- 
ified cholesterol does not readily exchange between 
membranes [21], these results may be considered as 
representative of a whole lipoprotein particle uptake 
process. The transfer of HDL free cholesterol from the 
subfractions to the hepatocytes was greater than that 
of cholesterol esters (table 2). Since for both subfrac- 
tions, the mass of cholesterol esters is greater than that 
of free cholesterol, these data are consistent with a 
facilitated transport of free cholesterol, probably 
through a diffusive pathway, dissociated from the 
uptake of the lipoprotein particle. 
Hypotheses suggesting that specific lipoprotein 
receptors may exist at the liver parenchymal cell sur- 
faces have been raised [9,10]. Fromthe data reported, 
some uptake specificity for different HDL subclasses, 
at least as relates to HDLZ and HDL3 cholesterol esters, 
is certainly indicated. The different apoprotein com- 
positions of the two HDL subfractions may be regarded 
as important in hepatic uptake [ 11. 
The concentration dependency of lipoprotein cho- 
lesterol transfer to cells was tested for HDLZ, where 
evidence for a more efficient cellular uptake was at 
hand. HDL, cholesterol ester internalization is not a 
linear function of pericellular HDLZ levels, the eff- 
ciency of transport being decreased at high concentra- 
tions (fig.1). Saturation of transport, however, was 
not observed up to 51 pg/rnl of medium HDLZ cho- 
lesterol. The HDLz cholesterol ester hydrolysis was, 
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yQ liDI. cholesterol esters 
Fig. 1. Cellular uptake of HDL, cholesterol esters: 24 h after 
seeding medium was changed for medium containing 20% 
lipoprotein-deficient rabbit serum and HDL, at different 
final cholesterol concentrations. Cells were incubated at 37°C 
for 4 h. Cellular lipid radioactivity was determined as in sec- 
tion 2. Each point is the mean from 2 independent deter- 
minations. 
at any tested concentration, directly related to intra- 
celhrfar transport (table2, fig.2). These findings clearly 
suggest that under the selected expe~ental condi- 
tions, liver paren~hymal cells do not accumulate cho- 
lesterol esters. In the time interval of the study, more- 
over, free cholesterol entering the cells was only negli- 
gibly esterified (table 2). Similar findings have been 
reported in [22] for chylomicron rermrant catabolism 
by liver parenchymal cells, and in [23] in human skin 
fibroblasts. 
Hydrolytic activities for interiorized cholesterol 
esters were also calculated (fig.2). V,, was 100 pg . 
h-’ . mg cellular protein-’ and I&, 5.88. These results 
are quite similar to those in (241 for the parenchym~ 
cell hydrolysis of chyio~~ron remnant cholesterol 
esters. However, a lower figure for Km was observed 
in 1241. Further experiments (unpublished) have 
I I I I I I I 
0.2 0 0.2 0.4 0.6 0.8 1 
1/ bl 
Fig.2. Lineweaver-Burk plot for HDL, cholesterol esters 
hydrolysis. Points were calculated from the results in fii.1, 
on knowledge of the mass of interiorized HDL, cholesterol 
esters undergoing hydrolysis (see section 2). 
shown that free and esterified cholesterol transfer for 
both HDL subfractions are tempera~re-dependent. 
At Lf°C free and ester cholesterol intern~zation is 
reduced to l/21 and 1115, respectively. 
The role of heparin in liver cell lipoprotein inter- 
nalization, be it direct or mediated by cellular elease 
of lipase activity [25], suggested testing the effect of 
the mucopolysaccharide in this system. Concentra- 
tions similar to those found in the plasma of treated 
patients [25] (l-10 U/ml) were used. The results 
(table 3) indicate a significant increase of cholesterol 
uptake, both free and ester, in parenchymal cells pre- 
incubated with heparin. This effect, although not sig- 
nificantly different between the two heparin concen- 
trations, appears, on the other hand, related to the 
HDLz medium cholesterol, being evident only at >14 
I.lgfml. 
Table 3 
Effect of heparin on the cellular uptake of HDL, free and esterified cholesterol 
HDL, cholesterol 
in medium kg/ml) 
Control 
FC 
+ Heparin (1 U/ml) + Heparin (10 U/ml) 
FC EC FC EC 
1.5 56.4 * 4.2 69.7 f 4.6 51.6 * 4.7 73.1 -t 3.3 41.7 * 3.9 62.8 t 4.5 
4.0 188.3i 7.8 126.7 f 5.6 183.9 i 4.8 102.0r 5.2 199.9 f 8.7 117.5 t 5.5 
16.0 403.2 * 10.9 187.2 2 3.9 510.3 f 8.8a 210.2 f 7.Ba 526.6 + 1 3.4a 217.5 t 9.8a 
32.0 752.1 i 18.7 322.2 i 15.1 1000.6 5 28.7a 418.4 f 13.2a 941.9 + 13.8a 387.1 +. 20.0a 
a p < 0.01 YS control (Student’s t-test for paired samples) 
Each value (ng cholesterol/mg cellular protein) is the mean + SD from 4 independent determinations 
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In conclusion, studies on the Uptake of cholesterol 
associated with the two major HDL subfractions, 
showed that the cholesterol ester transport into cells 
is markedly higher for HDLz, with an uptake pattern 
suggestive of a receptorial mechanism. Further studies 
are necessary to investigate whether HDLz inflow is 
associated with bile acid synthesis. The remarkable 
increase of HDLa cholesterol uptake induced by ther- 
apeutic concentrations of heparin, although with an 
unclear mechanism, isa finding of interest, in view of 
the proposed therapeutic effect of sulphated muco- 
polysaccharides in atherosclerotic conditions [26]. 
Supported in part by the Consigho Nazionale delle 
Richerche of Italy (P. F. Medicina Preventiva, Subpro- 
ject ATS no. 79 011 13.83). 
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